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Abstract. papillomavirus
cancer has been widely proven. Since this cancer occurs more frequently in immunosuppressed individuals, we sought
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fected prostitutes in Tegucigalpa, Honduras. Cervical scrapes were collected from 23 HIV-seropositive and 28 HIV- 
seronegative prostitutes for HPV DNA detection by the polymerase chain reaction. Fifty-six percent of the HIV- 
seropositive women and only 18% of the seronegative women were HPV DNA positive (odds ratio = 6.0). In addition, 
there was a significant association between seropositivity for HIV with a history of sexually transmitted diseases (P 
<  0.01). Our data confirm the association between infections with HIV and HPV.
Human immunodeficiency virus (HIV) is the causative 
agent' of the acquired immunodeficiency syndrome (AIDS). 
Infection with the virus is followed over widely varying pe- 
riods of time by progressive immunodeficiency and increas­
ing rates of infectious diseases and neoplasms.
Honduras has the highest incidence of AIDS cases in Cen­
tral America and up to January 1996, a total of 5,008 cases 
had been recorded, 65.7% males and 34.3% females.1 Fur­
thermore, the heterosexual spread of HIV in this country has
t
occurred at an alarming rate during the past four years, with 
the proportion of cumulative AIDS cases attributable to het­
erosexual contact increasing from 77% of the total number 
of cases in 1990 to 88% in 1995.1 This is even higher than 
that observed in the United States, Europe, and other Latin 
American countries.2
Of particular clinical significance are recent reports that 
women with HIV have a higher rate of cervical abnormali­
ties, including human papillomavirus (HPV) infection, ab­
normal Pap smears, and squamous intraepithelial lesions 
(SILs).1 5 This recognition of the importance of cervical dis­
ease in HIV infection has led the Centers for Disease Control 
and Prevention (Atlanta, GA) to include cervical cancer as 
an AIDS-delining illness in women.6
Epidemiologic and experimental data support the etiologic 
role of HPV in the development of cervical cancer.7 0 The 
oncogenic HPV genotypes (mainly 16 and 18) have been
in 80-90% of cervical 
(CIN) grade 3 lesions and invasive cervical cancers. The 
prevalence of particular HPV types varies between different 
geographic regions.10 In addition, CIN associated with gen­
ital HPV infection occurs with increased frequency and se­
verity among persons with immunodeficiency” and intra- 
genically immunosuppressed women after kidney transplan­
tation.12
A number of studies have indicated that the prevalence of 
HPV infection and HPV-induced epithelial abnormalities is 
higher in HIV-seropositive women than in HIV-seronegative 
women.13-15 Schrager and others1'’ in their study determined 
that 31% of HIV-infected women had cytologic squamous 
atypia, compared with only 4% of HIV-seronegative women. 
Feingold and others17 extended these observations, present­
ing molecular evidence of HPV infection in the cervicova- 
ginal epithelium of women with HIV infection. They found
that 49% of the HIV-infected women studied had HPV in­
fections compared with 25% of a group of non-HIV-infected 
women. In addition, 40% of the HIV-infected women had 
SILs on cervical cytology, compared with 9% of the non­
infected women. Recent reports have also described in­
creased rates of both HPV and anal dysplasia or neoplasia 
in HIV-positive men.18
Considering the high prevalence of HIV infection and tak­
ing into account that carcinoma of the cervix is the most 
common type of cancer among women in Honduras, it is of 
utmost importance to the public health interest to gain a 
better understanding of the association between HIV and 
HPV with respect to the development of cervical cancer. 
We are also not aware of any study that has addressed this 
problem in the Central American region. This investigation 
was designed to assess the possible association between 
HPV and HIV among prostitutes with and without HIV in­
fections in Tegucigalpa, Honduras.
SUBJECTS AND METHODS
Study population. Between November 1994 and Pebru
ary 1995, and 28 HIV-seronegative 
Crucitas
health care clinic and the clinic of the Nongovernmental Or­
ganization (NGO) Fight Against AIDS, both located in Te­
gucigalpa, Honduras were recruited for the study. These 
women were routinely screened for sexually transmitted dis­
eases because of their profession and were without any ev­
idence of gynecologic complaints. Participation in the study 
was voluntary and all women gave informed consent. The 
study was approved by the Ethical Commission of the Min 
istry of Health.
The Las Crucitas health care center of the Ministry of 
Public Health is a clinic for the control of sexually trans Bkl
mitted diseases where women attending supposedly at week­
ly intervals are routinely diagnosed and treated for syphilis, 
gonorrhea, and HIV. The NGO is located in the red light 
district of Tegucigalpa and was established in 1989 mainly 
to implement interventions aimed at reducing high-risk be­
havior in the HIV epidemic. Furthermore, medical care anti
advice is also provided to people already infected with the 
virus.
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T a b l e  1
Selected  demographic and behavioral characteristics in the study 
population*
HIV-seropositive 
(n = 23) 
Mean
HI V-s ero negative 
(n «  28) 
Mean
A ge (years) 33 31
No. o f  pregnancies 4 3
A ge at first pregnancy 16 16
A ge at first intercourse 15 16
* HIV -  human immunodeficiency vims.
All the women in the study, who defined themselves as 
prostitutes, were given a physical examination, including a 
pelvic examination. A vaginal secretion or genital ulcer di­
rectly visualized was noted. They were interviewed regard­
ing demographic variables and questions concerning HPV- 
associated risk factors, sexual history and practices, presence 
of sexually transmitted diseases, and use of oral contracep- 
lives. A blood sample was obtained from all woman for de­
tection of antibodies to HIV. No cytologic analysis was per­
formed for these women because of logistic and financial 
problems.
Serologic analysis for HIV. Sera were tested for anti­
bodies to HIV using a commercially available enzyme- 
linked immunoassay (HIVAB-HIV-1 EIA; Abbott Labora­
tories, North Chicago, IL). Positive and borderline samples 
were retested and confirmed by Western blot assay (Cam­
bridge Biotechnology, Worcester, MA). A Western blot was 
considered positive if two of the following bands were 
found: p24, gp41, or gp 120/160.
Detection of HPV DNA. For the analysis of HPV, cer­
vical scrapes were taken from the transformation zone of all 
women with a wooden spatula and the cells were eluted in 
5 ml of phosphate-buffered saline (PBS) containing 0.05%
ate. ills were vorte
leted, and resuspended in 0.5 ml of PBS and stored at - 2 0  C
ir vir
Extraction of DNA from the thawed cells was performed 
according to the standard sodium dodecyl sulfate-proteinase
as prK-phenol-c
AH samples were prescreened with the (3-globin primers
P C 03/P C 0421 to assess sample integrity. A general primer- 
mediated polymerase chain reaction PCR (GP-PCR) strategy 
was then followed for the analysis of the samples for the
presence of IIPV DNA.*- Briefly, the overall presence of 
HPV was assessed using a general primer set (GP5/GP6) 
directed against the late viral eapsid proteins (LI) open read­
ing frame, which is highly conserved among all papilloma­
viruses. This GP-PCR assay detects a broad range of genital 
HPV types as well as unidentified HPV types (HPV X). A 
low-stringency Southern blot analysis was performed with a 
cocktail probe consisting of GP-PCR products specific for 
HPV 6, 11, 16, 18, 31 and 33.22 To prevent contamination, 
strict spatial partitioning of the different technical steps of 
the PCR was done and the recommendations of Kwok and
were
Data analysis. Data were analyzed using Epi
for Disease Control and Prevention, Atlanta, G 
program. Statistical significance was by Fisher’s
T able 2
Comparison o f oral contraceptive use, STD , and ulcers’1'
HIV-positive
(n =  23)
HIV-negative
(h =  28) p
Oral contraceptive 7 10 0.77
STD history 19 9 <0.01
Ulcers 3 0 <0.09
* STD = sexually transmitted disease; HIV -  human immunodeficiency virus,
exact test. Any P value less than 0.05 was 
niiicant. The odds ratio (OR) and exact 95% 
terval (95% Cl) were calculated to measure 





The general characteristics of the 51 prostitutes concern­
ing age and selected behavioral variables are summarized in 
Table 1. The HIV-seropositive and -seronegative women en­
rolled in this study did not differ significantly from each 
other for these characteristics. The women were in their ear­
ly 30s, all had had at least one pregnancy, and had experi­
enced their first sexual intercourse and first pregnancy before 
the age of 20.
Differences between HIV-positive and HIV-negative pros­
titutes concerning use of oral contraceptives, history of sex­
ually transmitted diseases, and presence or absence of ulcers 
in the genital area were further analyzed. As shown in Table 
2, HIV-seropositive women reported more frequently a his­
tory of sexually transmitted diseases than HIV-negative 
women (P <  0.01). The presence of ulcers in the genital 
area was of a borderline significance (P <  0.09). There was
no difference in use of oral contraceptives among HIV-se­
ropositive and HIV-seronegative women (30% and 35%, re-
As seen in Table 3, a total of 18 (35%) of 51 prostitutes 
tested positive for HPV DNA by PCR: 13 (56.5%) of 23 of 
the HIV-positive women compared with only 5 (18.0%) of 
28 of the HIV-negative women, giving a strong association 
between detection of I-IPV DNA in cervical scrapes and pos- 
itivity for antibody to HIV in serum (OR — 6.0, 95% Cl =
1.5- 26.7).
.SC US”
as a high-risk group for all sex­
ually transmitted diseases, including infections with HPV 
and HIV. In Honduras, the number of AIDS cases and the 
seroprevalence of HIV infection among prostitutes has been
increasing. According to Mann and others,2'1 the
of HIV infection among female prostitutes in San 
Pedro Sula, the second largest city in Honduras with the
T able 3
Prevalence o f human p< avirus DNA*
HIV- posili ve 
(n 23)




* HIV ~ human immunodeficiency virus; OR -  odds ratio; Cl * confidence inter vu!.
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highest incidence of AIDS cases, has increased from 19% 
in 1987 to 37% in 1990.
The results of our survey indicate that women practicing 
prostitution and testing positive for antibodies to HIV had a 
six-fold increased risk for HPV infection as compared with 
HIV-negative prostitutes. The association between HPV in­
fection and HIV infection found in this study parallels the 
results from other countries.14,15 Laga and others,14 in a study 
among prostitutes in Kinshasa, Zaire, reported a significant 
association of HPV infection and CIN with HIV seropositiv- 
ity. Eight (73%) of 11 seropositive women with CIN had 
HPV detected in that study. Vernon and others,25 in another 
study among prostitutes also in Kinshasa, Zaire of HPV 
DNA in HIV-1-seropositive and -seronegative women, 
showed that detection of HPV DNA in the cervix was highly 
associated with HIV-1 seropositivity. They estimated a 
42.8% prevalence of HPV in HIV-1-seropositive women and 
13.4% in seronegative women.
In a study of mainly intravenous, hard drug-using, HIV- 
infected prostitutes in Amsterdam, The Netherlands, van 
Doomum and others26 demonstrated that in this group HIV 
infection was associated with a higher prevalence of HPV 
infection but not with a higher rate of abnormal cervical 
cytology. These results are comparable with the findings of 
a study among prostitutes in Nairobi, Kenya, in which 37% 
of 147 HIV-positive women and 24% of 51 HIV-negative 
women were found to be positive for cervical HPV DNA.27 
Nevertheless, the 1.7-fold increase in the risk of cervical 
HPV infection associated with HIV infection was not statis­
tically significant. These investigators indicated that their re­
sults were caused by the composition of their study popu­
lation, which included only a small number of women with 
advanced HIV-related °ase and by the occurrence of 
HPV-related disease after a long latent period. A recent study 
among women in Malawi reported that HIV-infected women 
had twice the risk of abnormal cervical cytology than un­
infected ones and were more likely to have persistent HPV 
infections (48% versus 23%).2K
In our study, HPV DNA was found in 56.5% of the HIV- 
seropositive prostitutes. A higher prevalence of HPV infec­
tion in HIV-infected women may be the first step leading to 
dysplastic lesions. Data from a study by Koutsky and oth­
ers24 of CIN support the hypothesis that high-grade lesions 
may develop early in the course of HPV infection. Since the 
progression to invasive disease is more aggressive in the 
HIV population, they need closer surveillance at clinics that 
provide frequent cytologic screening and appropriate coun­
seling.
Although our study sample size was small, it included 
HIV-negative controls and the women were relatively ho­
mogeneous in terms of sexual activity and high exposure 
risk for HIV. In addition, HPV DNA was assayed with a 
sensitive GP-PCR, which detects a broad spectrum of genital 
HPVs,22 whereas some previous studies have estimated HPV 
infection based on cervical cytology.15-I() Cytologic evidence 
o f HPV infection is highly subjective, with koilicytotic atyp- 
ia, characterized by the presence of cells with perinuclear 
cytoplasmic vacuolation, nuclear enlargment, and regarded 
as the hallmark of HPV infection, being the only patho­
gnomonic finding. This suggest that PCR-based HPV detec-
tion methods could reduce the underestimation of the asso­
ciation of HPV and HIV infection found in some studies.
In conclusion, it may be stated that in this group of 
HIV-positive and HIV-negative prostitutes the prevalence of 
cervical HPV DNA was found to be associated with HIV 
infection.
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